Advertisement

Usefulness of Fasting Plasma Glucose to Predict Mortality or Coronary Heart Disease in Persons ≥60 Years of Age Without Diabetes Mellitus or in Those With Undiagnosed Diabetes Mellitus (from The Dubbo Study)

      The role of fasting plasma glucose (FPG) levels below diabetes “thresholds” in predicting mortality or coronary heart disease (CHD) is unclear. This study examines whether FPG predicts mortality or CHD in subjects without diabetes (historical or undiagnosed) or in those with undiagnosed diabetes (or lesser degrees of glucose intolerance). We have analyzed all-causes mortality and CHD incidence from a 16-year follow-up in a cohort of Australian senior citizens, 60 years and older, first examined in 1988–89. Diabetes was defined on historical grounds or by use of medication; undiagnosed diabetics were those without history but with FPG >124 mg/dl. Hazard ratio and 95% confidence intervals of the specified outcomes were obtained from Cox models, with FPG being entered as a continuous variable. Mortality and CHD incidence rates in subjects with previous cardiovascular disease (CVD) and diabetes were substantially higher than in nondiabetics, but CHD rates were disproportionately higher in diabetic women. FPG did not significantly predict any outcome in men in the absence of diabetes. In women, FPG was a significant predictor of death (hazard ratio = 1.30, 95% confidence interval 1.09 to 1.56) and CHD (hazard ratio 1.24, confidence interval 1.02 to 1.51) in the cohort, which included previous CVD but excluded all diabetes. In women with undiagnosed diabetes, FPG predicted death independently of previous CVD presence but did not predict CHD. In conclusion, FPG in the range of 95 to 108 mg/dl in a nondiabetic woman is still of prognostic importance for survival or CHD if she has previous CVD, whereas FPG is of prognostic importance for survival if she has undiagnosed diabetes. No similar findings were made in men.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ford E.S.
        • de Stefano F.
        Risk factors for mortality from all-causes and from coronary heart disease among persons with diabetes: Findings from the National Health & Nutrition Examination Survey I Epidemiologic Follow-Up Study.
        Am J Epidemiol. 1991; 133: 1220-1230
        • Knuiman M.W.
        • Welborn T.A.
        • Wittall D.E.
        An analysis of excess mortality rates for persons with non-insulin dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model.
        Am J Epidemiol. 1992; 135: 638-648
        • Stamler J.
        • Wentworth D.
        • Vaccaro O.
        • Neaton J.D.
        Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.
        Diabetes Care. 1993; 16: 434-444
        • Simons L.A.
        • McCallum J.
        • Friedlander Y.
        • Simons J.
        Diabetes, mortality and coronary heart disease in the prospective Dubbo Study of Australian elderly.
        Aust New Zeal J Med. 1996; 26: 66-74
        • Coutinho M.
        • Gerstein H.C.
        • Wang Y.
        • Yusuf S.
        The relationship between glucose and incident cardiovascular events.
        Diabetes Care. 1999; 22: 233-240
        • Levitan E.B.
        • Song Y.
        • Ford E.S.
        • Liu S.
        Is nondiabetic hyperglycemia a risk factor for cardiovascular disease?.
        Arch Intern Med. 2004; 164: 2147-2155
        • Smith N.L.
        • Barzilay J.I.
        • Shaffer D.
        • Savage P.J.
        • Heckbert S.R.
        • Kuller L.H.
        • Kronmal R.A.
        • Resnick H.E.
        • Psaty B.M.
        Fasting and 2-hour post challenge serum glucose measures and risk of incident cardiovascular events in the elderly.
        Arch Intern Med. 2002; 162: 209-216
        • Eguchi K.
        • Boden-Albala B.
        • Jin Z.
        • Di Tullio M.R.
        • Rundek T.
        • Rodriguez C.J.
        • Homma S.
        • Sacco R.L.
        Usefulness of fasting blood glucose to predict vascular outcomes among individuals without diabetes mellitus (from the Northern Manhattan Study).
        Am J Cardiol. 2007; 100: 1404-1409
        • Levitzky Y.S.
        • Pencina M.J.
        • D'Agostino R.B.
        • Meigs J.B.
        • Murabito J.M.
        • Vasan R.S.
        • Fox C.S.
        Impact of impaired fasting glucose on cardiovascular disease.
        J Am Coll Cardiol. 2008; 51: 264-270
        • Simons L.A.
        • McCallum J.
        • Friedlander Y.
        • Simons J.
        • Powell I.
        • Heller R.
        Dubbo Study of the elderly: sociological and cardiovascular risk factors at entry.
        Aust New Zeal J Med. 1991; 21: 701-709
      1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
        Diabetes Care. 1997; 20: 1183-1201
        • Pankow J.S.
        • Kwan D.K.
        • Duncan B.B.
        • Schmidt M.I.
        • Couper D.J.
        • Golden S.
        • Ballantyne C.M.
        Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance.
        Diabetes Care. 2007; 30: 325-331
        • Park S.
        • Barrett-Connor E.
        • Wingard D.
        • Shan J.
        • Edelstein S.
        GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes: the Rancho Bernardo Study.
        Diabetes Care. 1996; 19: 450-456
        • The DECODE Study Group
        Glucose tolerance and cardiovascular mortality.
        Arch Intern Med. 2001; 161: 397-404
        • Gerich J.E.
        Clinical significance, pathogenesis, and management of postprandial hyperglycemia.
        Arch Intern Med. 2003; 163: 1306-1316
        • King G.L.
        • Wakasaki H.
        Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes.
        Diabetes Care. 1999; 22: C31-C37